digitalmarket

The major factors driving the growth of Digital X-ray Market include the increasing geriatric population and growth in disease incidence as well as favorable government regulations, investments, and initiatives. The advantages of digital X-ray systems have played a key part in their adoption; their speed and accuracy, as well as quick processing times, allow for significantly higher patient screening volumes than earlier. This has pushed companies to focus on product development and innovation. The global digital X-ray market is expected to reach USD 16.4 billion by 2026 from an estimated USD 11.1 billion in 2021, at a CAGR of 8.1% from 2021 to 2026. Download PDF Brochure: -https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=1164 Market Segmentation: - Based on technology, the market is segmented into direct radiography and computed radiography. The direct radiography segment commanded the largest share of the global market in 2020. The major benefit of DR-based systems over film and CR systems is that images are sent directly to a computer screen from the X-ray imaging plate, thereby eliminating the need to retrieve the image plate for processing images or taking a second X-ray shot. An effective dynamic range, better medical evaluation, superior and accurate image capture, reduced radiation exposure for patients and workers, flexibility in image management, improved patient throughput, superior evaluation of data and images, and lower operational costs are some of the other advantages of DR systems. Due to these advantages, the use of DR systems is on the rise. Based on portability, the digital X-ray market is segmented into fixed digital X-ray systems and portable digital X-ray systems. Fixed digital X-ray systems include floor-to-ceiling-mounted systems and ceiling-mounted systems, while portable digital X-ray systems include mobile X-ray systems and handheld X-ray systems. The portable digital X-ray systems are expected to grow with the highest CAGR during the forecasted period. Portable X-ray systems are light and can be transported to any desired location. These systems are especially useful in a variety of radiographic imaging set-ups, including intensive care units, cardiac care units, neonatal intensive care units, operating rooms, emergency rooms, and at the patient's bedside for critically ill patients or patients with mobility challenges. The global digital X-ray systems market is divided into new and retrofit digital X-ray systems. The retrofit digital X-ray systems segment is expected to dominate the market during the forecast period. The large share of this segment can be attributed to the greater adoption of retrofit systems among end users due to their lower cost compared to new digital X-ray systems. Based on end users, the X-ray market is segmented into diagnostic centers, hospitals, and dental care centers. Hospitals are expected to dominate the market during the forecast period. Hospitals constantly require advanced diagnostic systems that enable the screening and diagnosis of a large number of patients in a short time period. This is a key factor driving market growth. Based on applications, the market is segmented into general radiography, dental applications, fluoroscopy, cancer, and mammography applications. The general radiography segment is expected to dominate this market during the forecast period. Growth in this market can be attributed to the increasing prevalence of target diseases, high demand for early diagnosis and diagnostic imaging, and technological advancements in the digital X-ray systems market. Regional Analysis: - The digital X-ray market is segmented into five major regions—North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. North America is the largest regional market for digital X-ray systems, whereas the Asia Pacific market is estimated to grow at the highest CAGR during the forecast period. Growth in the digital X-ray market in the Asia Pacific is mainly driven by the growing geriatric population, particularly in Japan; increasing disposable incomes, allowing for greater affordability for advanced technologies; the rising prevalence of target diseases; and favorable government initiatives. Such factors help to drive the market for digital imaging systems in this region and draw foreign investments and partnerships. Request Sample Pages :-https://www.marketsandmarkets.com/requestsampleNew.asp?id=1164 Top Key Players: -  The digital X-ray market is dominated by Siemens Healthineers (Germany), GE Healthcare (US), Koninklijke Philips N.V. (Netherlands), FUJIFILM Holdings Corporation (Japan), and Canon, Inc. (Japan). The other leading market players include Carestream Health (US), Shimadzu Corporation (Japan), Hologic Inc. (US), Agfa-Gevaert Group (Belgium), Samsung Medison (South Korea), and Konica Minolta (Japan).  

Advancements in IT have provided an ever-expanding array of options like advanced broadband networks, mobile devices and networks, remote patient monitoring, high-definition video conferencing, and EHRs. This has generated significant opportunities for clinical workflow solution vendors. With the help of these integration solutions, the use of peripheral medical devices has enabled patients to remotely monitor their vital signs, such as blood pressure, weight, glucose levels, ECG, and body temperature, at home (with the data automatically being sent to a nurse or physician). The Clinical Workflow Solutions Market  is projected to reach USD 18.1 billion by 2025 from USD 9.1 billion in 2020, at a CAGR of 14.8% during the forecast period. Ask for PDF Brochure: -https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=146901412 Market Segmentation: - Based on products, the clinical workflow solutions market is segmented into workflow automation solutions, care collaboration solutions, real-time communication solutions, data integration solutions, and enterprise reporting and analytics solutions. The data integration segment is estimated to account for the largest market share in 2019. The large share of this segment can be attributed to the increasing demand for using medical records and integrating them across hospital departments has been one of the major drivers for data integration solutions. Based on end users, the clinical workflow solutions market is segmented into hospitals, long-term care facilities, and ambulatory care facilities. The hospital segment is estimated to account for the largest market share in 2019. Market Drivers: 1 Advantages of clinical workflow solutions in enhancing patient care and safety 2 Government initiatives for HCIT adoption 3 Growing adoption of EHRs and other HCIT solutions 4 Increasing patient volume due to the rising prevalence of chronic diseases and COVID-19 5 Rising need to curtail healthcare costs Regional Analysis: - North America is expected to account for the largest share of the clinical workflow solutions market in 2019, followed by Europe. The dominance of the North American region can be attributed to the growing healthcare IT spending, developed infrastructure, evolving regulations for better healthcare outcomes, and the presence of major market players in the region. Request for Sample Pages: – https://www.marketsandmarkets.com/requestsampleNew.asp?id=146901412 ; Top Key Players: - The prominent players in the clinical workflow solutions market are are Hill-Rom Holdings, Inc. (US), Ascom Holding AG (Switzerland), GE Healthcare (US), Koninklijke Philips N.V. (Netherlands), Cisco Systems, Inc. (US), Stanley Black & Decker, Inc. (US), Cerner Corporation (US), Infor, Inc. (US), Allscripts Healthcare Solutions, Inc. (US), and McKesson Corporation (US).  

The growth of Molecular Quality Controls Market is primarily driven by factors such as the rising adoption of third-party quality controls, increasing number of accredited clinical laboratories, the rising demand for external quality assessment support, increasing government funding to support genomics projects, increasing demand for personalized medicines and declining costs of sequencing procedures and increasing prevalence of infectious diseases, cancer & genetic diseases. The molecular quality controls market size is expected to grow from USD 164 million in 2021 to USD 226 million by 2026, at a CAGR of 6.7% during the forecast period.  Download PDF Brochure: -https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=82625523 Market Segmentation: Based on product, the molecular quality control market is segmented into Independent Controls and Instrument Specific Controls. The Independent control segment accounted for the largest share of the market in 2020. The increasing number of accredited laboratories and mandates for the use of quality controls from regulatory bodies to ensure the accuracy of diagnostic test results are driving the growth of the molecular quality control products market. Based on analyte type, the market is segmented into single-analyte controls and multi-analyte controls. Single-analyte controls dominated the molecular quality controls market in 2020 due to the significant use of singleplex assays in hospitals and the advantages associated with the use of single-analyte controls, such as simple analysis & interpretation and low risk of cross-reactivity. Based on application, the molecular quality control market is segmented into infectious disease diagnostics, oncology testing, genetic testing, and other applications. The infectious disease diagnostics segment accounted for the largest share of the molecular quality controls market in 2020. The large share of this segment is attributed to the development of advanced assays for infectious diseases, a significant increase in the prevalence of infectious diseases, and the rising awareness about the effective use of molecular diagnostic technologies to control the occurrence and spread of infectious diseases. The key end users of molecular quality controls studied in this report include diagnostic laboratories, hospitals, IVD Manufacturers and CROs Academic & Research Institutes, and other end users. The Diagnostic Laboratories segment accounted for the largest share of the market in 2020, increasing number of accredited diagnostic laboratories to provide growth opportunities in the coming years. Regional Analysis: The molecular quality control market is segmented into five major regions, namely, North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. In 2020, North America was the largest regional market for molecular quality controls due to the developed healthcare system in the US and Canada, the presence of many leading molecular quality control product manufacturers in the region, and the easy accessibility to technologically advanced products in the region.  Recent Developments In June 2021, SeraCare partnered with the International Quality Network for Pathology (IQN Path) (Luxembourg) to develop, manufacture, and supply a range of highly characterized cell line genomic DNA and formalin-fixed, paraffin-embedded (FFPE) standards with confirmed low, mid, and high levels of mutational burden within their exome regions In May 2021, Bio-Rad entered a global partnership with Roche Diagnostics (Switzerland) to provide its customers access to a complete line of InteliQ products and Unity QC data management solutions along with customer training and support services. In 2020, Abbott Laboratories invested USD 2.4 billion in R&D, of which USD 10.80 billion was invested in developing technologically advanced diagnostic products to strengthen its product portfolio. Request Sample Pages: -https://www.marketsandmarkets.com/requestsampleNew.asp?id=82625523 Top Key Players: The prominent players in the molecular quality controls market are F. Hoffmann-La Roche Ltd. (Switzerland), Bio-Rad Laboratories, Inc. (US), Thermo Fisher Scientific, Inc. (US), Randox Laboratories Ltd. (UK), LGC Limited (UK), Abbott Laboratories (US), Fortress Diagnostics (UK), SERO AS (Norway), Anchor Molecular (US), Ortho-Clinical Diagnostics, Inc. (US), Quidel Corporation (US), Sun Diagnostics, LLC (US), Seegene Inc. (South Korea), ZeptoMetrix, LLC (US), Qnostics (UK), Bio-Techne Corporation (US), Microbiologics, Inc. (US), Microbix Biosystems Inc. (Canada), SpeeDx Pty. Ltd. (Australia), Maine Molecular Quality Controls, Inc. (US), and Grifols, S.A. (Spain). Conclusion: In conclusion, the molecular quality controls market is an important segment of the clinical diagnostics industry, focused on providing quality control materials and services for molecular diagnostic testing. The market is driven by the increasing demand for molecular diagnostics in healthcare, as well as the need for reliable and accurate diagnostic testing. The market includes both internal and external quality controls, and a range of molecular quality control materials such as nucleic acid controls, protein controls, and whole cell controls. The major players in the market provide a range of quality control materials and services to clinical laboratories, research institutions, and diagnostic manufacturers around the world. Overall, the molecular quality controls market is expected to continue to grow in the coming years, driven by the increasing demand for molecular diagnostics and the need for reliable and accurate testing.

The increasing incidence of chronic kidney disease, the availability of advanced dialysis, machines disposables and replacement fluids, and increasing government initiatives to increase the accessibility of dialysis treatment and growing adoption home hemodialysis are expected to drive market growth in the coming years The global Hemodialysis Market is projected to reach USD 105.1 billion by 2026 from USD 76.9 billion in 2021, at a CAGR of 6.4% during the forecast period. Download PDF Brochure:-  https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=1279 Market Segmentation:- The hemodialysis and peritoneal dialysis market include major Tier I and II suppliers of HD & PD products & services are Fresenius Medical Care AG & Co. KGaA (Germany), Baxter International, Inc. (US), Nikkiso Co., Ltd. (Japan), B. Braun Melsungen AG (Germany), Asahi Kasei Corporation (Japan), DaVita Inc. (US), Nipro Corporation (Japan), Cantel Medical Corporation (US), Diaverum (Germany), Medtronic plc (Ireland), Rockwell Medical, Inc. (US), Becton, Dickinson and Company (US), Dialife SA (Switzerland), and Isopure Corp. (USThese suppliers have their manufacturing facilities spread across regions such as North America and Europe. Significant rise in number of dialysis service provider, coupled with the growing prevalence of ESRD. Along with this growing focus of dialysis service providers towards expansion of their services offerings by launching and acquiring new dialysis centers across the globe is likely to contribute towards the growth of the segment. Regional Analysis:- Geographically, the emerging Asian countries, such as China, India, Japan and Singapore, are offering high-growth opportunities for market players. The Asia Pacific point of care market is projected to grow at the highest CAGR of 8.8% from 2021 to 2026. Expansion of healthcare infrastructure and increase in disposable personal income, increase patient population with acute kidney disease, diabetes, hypertension are factors likely to support the growth of hemodialysis and peritoneal dialysis market in the region Request Sample Pages:- https://www.marketsandmarkets.com/requestsampleNew.asp?id=1279 Top Key Players:- Prominent players in this Hemodialysis Market are Baxter International Inc. (US), Fresenius Medical Care AG & Co. KGaA (Germany), NIKKISO CO., LTD. (Japan), B. Braun Melsungen AG (Germany), Asahi Kasei Corporation (Japan), Toray Medical Co., Ltd. (Japan), among others

The benefits offered by membrane chromatography over conventional chromatography methods, increasing biopharmaceutical R&D, and increasing regulatory scrutiny on the cleaning validation of downstream purification processes are the major factors driving the growth of the membrane chromatography market. The report Membrane Chromatography Market  is estimated to grow from USD 198 million in 2020 to USD 408 million by 2025, at a CAGR of 15.5% during the forecast period. Ask For PDF Brochure: - https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=151487196 ; Market Segmentation:- Based on product, the membrane chromatography market is segmented into consumables and accessories. The consumables segment is further divided into capsules, cassettes, and cartridges; syringe filters; membrane discs and sheets; spin columns; filter plates; and other consumables (such as pipettes, syringes, vials, and collection plates).  The ion exchange membrane chromatography segment accounted for the largest share of the membrane adsorbers market in 2019. Advantages associated with ion exchange membrane chromatography such as reliability, accuracy and precision, high selectivity and speed, scalability, high separation efficiency, and low cost of consumables and disposables are supporting the growth of this segment. The flow-through membrane chromatography segment accounted for the largest share of the membrane adsorbers market in 2019.  Based on end user, the global Membrane adsorbers market is segmented into pharmaceutical and biopharmaceutical companies, CROs, and academic and research institutes.  Key Market Drivers: -            1 Benefits offered by membrane chromatography over conventional chromatography techniques             2 Increasing biopharmaceutical R&D             3 Increasing regulatory scrutiny on the cleaning validation of downstream purification processes Regional Analysis: In 2019, North America accounted for the largest share of the global Membrane adsorbers market, followed by Europe.  Request for Sample Pages: -  https://www.marketsandmarkets.com/requestsampleNew.asp?id=151487196 ; Key Market Players:- The major companies in the global membrane chromatography market are Sartorius AG (Germany), Danaher Corporation (US), Merck Millipore (Germany), Thermo Fisher Scientific (US), and 3M Company (US).  

The growth in bioimpedance analyzers market is attributed to the prevalence of lifestyle diseases such as obesity, increasing awareness on healthy lifestyles, and the growing number of fitness clubs, weight loss clinics, and sports rehabilitation centers. The global Bioimpedance Analyzers Market size is projected to reach USD 767 million by 2026 from USD 429 million in 2021, at a CAGR of 10.2%. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=144536297 ; Market Segmentation: Based on the product, the bioimpedance analyzers market is segmented into multi-frequency bioimpedance analyzers, single-frequency bioimpedance analyzers, and dual-frequency bioimpedance analyzers. In 2020, the multi-frequency bioimpedance analyzers segment accounted for the larger share of the bioimpedance analyzers market. The preference for multi-frequency bioimpedance analyzers is high among end users as they can be used for both segmental and whole-body measurement, unlike single-frequency bioimpedance analyzers. Based on the modality, the bioimpedance analyzers market is segmented into wired bioimpedance analyzers and wireless bioimpedance analyzers. The wireless bioimpedance analyzers segment accounted for the largest market share in 2020. The advancements in and the growing demand for wireless technologies are major driving factors for this market. Based on end-users, the bioimpedance analyzers market is segmented into hospitals, fitness clubs and wellness centers, home users, and other end users. The fitness clubs and wellness centers segment accounted for the largest market share in 2020 due to the increasing number of fitness clubs and wellness centers, the growing awareness about health and fitness. Regional Analysis: The bioimpedance analyzers market is segmented into four major regional segments, namely, North America, Europe, Asia Pacific, and the Rest of the World. In 2020, North America accounted for the largest share of the bioimpedance analyzers market. The large share of North America can be attributed to factors such as the growing obesity rate, government initiatives to encourage healthy lifestyles, increasing use of body composition analyzers for assessing athlete fitness, and increasing number of health clubs and fitness centers. Request for Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=144536297 ; Top key Players: The major players in the bioimpedance analyzers market are Omron Corporation (Japan), Tanita Corporation (Japan), InBody (South Korea), RJL Systems (US), seca GmbH & Co. KG (Germany), EVOLT 360 (Australia), SELVAS Healthcare (South Korea), Charder Electronic Co. Ltd. (China), Fook Tin Group Holding Ltd. (China), Bodystat Ltd. (UK), Maltron International (UK), Biotekna (Italy), Withings (France), Biodynamics Corporation (US), Akern (Italy), Xiaomi (China), Sino-Hero (Shenzhen) Bio-Medical Electronics Co., Ltd. (China), Lumsail Industrial Inc. (China), Guangzhou Beautylife Electronic Technology Co., Ltd. (China), and Bioparhom (France).  

The Asia Pacific market is mainly driven by the overall growth of the medical devices market, mainly due to the rising disease prevalence, life expectancy, and geriatric population. Technological advancements have prompted end users to overhaul or update their manufacturing systems. As this is a costly process, they look to outsource contract manufacturing. However, market growth is impeded by the growing consolidation in the medical devices market. To develop their own manufacturing capabilities and save costs, Larger players are focusing on acquiring smaller players and CMOs themselves. This may affect the overall market growth to a certain extent. The Medical Device Outsourced Manufacturing Market is projected to reach USD 56.2 billion by 2026 from USD 29.3 billion in 2021 and is expected to grow at a CAGR of 13.9% during the forecast period. Browse in-depth TOC on "Medical Device Outsourced Manufacturing Market" 200 – Tables  61 – Figures 306 – Pages Download PDF Brochure:-https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=477468   The IVD devices segment accounted for the largest share of Asia Pacific medical device outsourced manufacturing market in 2020 Based on device type, the Asia Pacific market is broadly segmented into IVD devices, diagnostic imaging devices, cardiovascular devices, drug delivery devices, orthopedic devices, respiratory care devices, ophthalmology devices, surgical devices, diabetes care devices, dental devices, endoscopy devices, gynecology/urology devices, personal care devices, neurology devices, and other devices. In 2020, the IVD devices segment accounted for the largest share of the Asia Pacific market. The large share of this segment can be attributed to the increasing volume of IVD tests performed globally, increasing availability of IVD kits and reagents in the market, a growing number of hospitals and clinical laboratories in developing countries, automation and technological advancements in instruments with high-throughput capabilities, high demand for IVD tests in the COVID-19 pandemic, and advances in life science research. Class II medical devices segment accounted for the largest share of APAC market in 2020. Based on the class of device, the medical device outsourced manufacturing market is segmented into Class I, Class II, and Class III medical devices. In 2020, the Class II medical devices segment accounted for the largest share of the Asia Pacific market. The large share of this segment can be attributed to the large number of medical devices outsourced that fall under this device class and the utilization of a higher volume of these devices by end users and caregivers in the healthcare industry. In 2020, device development and manufacturing services segment accounted for the largest share of the Asia Pacific market Based on service, the Asia Pacific medical device outsourced manufacturing market is segmented into device development and manufacturing services, quality management services, packaging and assembly services and other services. In 2020, the device development and manufacturing services segment dominated this market. The increasing adoption of contract manufacturing services in the medical device industry, growth in the medical devices market (especially in the single-use disposable medical devices market), and improving device development and manufacturing capabilities are the major factors responsible for the large share of this segment. Request for Sample Pages:- https://www.marketsandmarkets.com/requestsampleNew.asp?id=477468 ; In 2020, production segment accounted for the largest share of Asia Pacific medical device outsourced manufacturing market Based on process, the Asia Pacific market is broadly segmented into production, prototyping, pilot production, design for manufacturing, process evaluation, validation, project management, packaging, and assembly. In 2020, the production segment accounted for the largest share of the market. The large share of this segment can be attributed to the growing number of medical device companies outsourcing their production tasks to minimize manufacturing costs. China is expected to witness fastest growth during the forecast period of 2021–2026. The Asia Pacific medical device outsourced manufacturing market, by country, has been segmented into China, Japan, Malaysia & Singapore, India, Australia & New Zealand, South Korea, and the Rest of APAC. China is expected to witness fastest growth during the forecast period of 2021–2026. China's fastest growth is mainly due to the lower cost of raw materials and labor in the country than in developed countries. The increasing demand for medical devices due to improving healthcare infrastructures, adoption of technologically advanced products, and increasing awareness of diagnosis are also expected to drive the growth of this market. The prominent players in this medical device outsourced manufacturing market are Flex, Ltd. (Singapore), Jabil, Inc. (US), TE Connectivity, Ltd. (Switzerland), Sanmina Corporation (US), Nipro Corporation (Japan), Celestica International (Canada), Plexus Corporation (US), Benchmark Electronics, Inc. (US), Integer Holdings Corporation (US), Gerresheimer Ag (Germany), West Pharmaceutical Services, Inc. (US), Nortech Systems, Inc. (US), Consort Medical PLC (UK), Kimball Electronics Inc. (US), and Teleflex Incorporated (US), Nordson Corporation (US), Tecomet, Inc. (US), SMC Ltd. (US), Nemera (France), and Tessy Plastics Corporation (US), among others.